SCHEMBL11265993

SCHEMBL11265993

COc1nncc(-c2cccc(C(F)(F)F)c2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 1/20 0.47
IDO1 P14902 1/20 0.47
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 3/20 0.46
MAOA P21397 2/20 0.46
GPR55 Q9Y2T6 1/20 0.46
CTSS P25774 1/20 0.45
NR1H4 Q96RI1 1/20 0.44
PDE4B Q07343 2/20 0.44
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CG P48736 1/20 0.44
NOTUM Q6P988 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11336031 0.80 PTGDR (0.49) MAPTHSD17B10NOTUMKDM4EALDH1A1
SCHEMBL8740137 0.79 MAOA (0.55) F2RL3IDO1HSD17B10MAOAGPR55
SCHEMBL3398455 0.78 ADORA2A (0.56) IDO1MAPTCTSSPIK3CDPIK3CA
SCHEMBL11329822 0.78 NOTUM (0.46) F2RL3IDO1MAPTPDE4BNOTUM
SCHEMBL11278322 0.78 ALDH1A1 (0.58) IDO1LMNAMAPTHSD17B10CTSS
SCHEMBL11269321 0.77 MAPT (0.61) LMNAMAPTMAPK1HSD17B10KDM4E
SCHEMBL11266115 0.75 MAPT (0.52) IDO1MAPTCTSSPIK3CDPIK3CA
SCHEMBL10836184 0.74 KDM4E (0.53) IDO1HSD17B10CTSSNOTUMKDM4E
SCHEMBL11339337 0.74 RAC1 (0.49) MAPTMAPK1HSD17B10NPSR1KDM4E
SCHEMBL8740103 0.73 MAOA (0.52) F2RL3IDO1MAPK1HSD17B10MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4157392-A HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS AND NERVOUS SYSTEM EFFECTS DIAMOND SHAMROCK CORPORATION (US) 1979-06-05 US claimed
US-4310551-A Pharmacologically active substituted 1,2,4-triazines DIAMOND SHAMROCK CORPORATION (US) 1982-01-12 US disclosed
US-4251527-A ANTIINFLAMMATORY AGENTS DIAMOND SHAMROCK CORPORATION (US) 1981-02-17 US disclosed
US-4157392-A HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS AND NERVOUS SYSTEM EFFECTS DIAMOND SHAMROCK CORPORATION (US) 1979-06-05 US disclosed